Antares Vision, a leading supplier of inspection and track and trace systems for the pharmaceutical industry, began today a six-day series of events celebrating the completion of its new corporate campus. Activities include technical meetings with supply chain partners and leading global pharmaceutical companies that are members of the company’s users group, technology demonstrations, family and general public open houses, and the unveiling of original contemporary artwork commissioned for the new corporate campus.

The new Antares Vision campus in Travagliato, which is about 50 miles (82km) north-east of Milan, triples the space formerly available to the company and will initially accommodate more than 150 staffers. The campus includes a new 29,000ft2 (2,700m2) three-story headquarters facility, a new 6,500ft2 (600m2) customer and employee training center with technology demonstration areas, and a renovated 19,000ft2 (1800m2) state-of-the-art manufacturing and global distribution centre.

"2015 has been momentous for our eight-year-old company", said Emidio Zorzella, Antares Vision CEO. "We were named one of the top businesses in Europe with special mention of our global growth strategy. Many of the world’s top 20 pharmaceutical companies became members of our new users group. We saw the installation of our 100th track and trace system and our 500th serialization line, and now we are dedicating a stunningly beautiful corporate campus in Northern Italy. We have a team of people that simply cannot be beat in terms of pharmaceutical inspection and track and trace technology expertise and dedication to customer service".

Partner and customer conferences to discuss future innovations

Four days (October 20-23) of the six-day celebration focus on upcoming technology developments for pharmaceutical track and trace and the market and regulatory trends helping to shape those developments. During these four days, Antares Vision will host key members of its supply chain, including manufacturers’ representatives, system integrators, and original equipment manufacturers (OEMs) at these meetings.

Following the sales channel meetings, the company will convene the first gathering of its users group at the new campus. The users group includes representatives of many of the top 20 pharmaceutical companies in the world and discusses best practices. In addition to Antares Vision talks and technology demonstrations, there will be presentations by: Jean Marc Bobée, Director, Industrial Anti-Counterfeiting Strategy at Sanofi; Ian Personage, Director, Global Serialization Services at PCI, the largest co-packer in the world; Marcelo Liebhardt, Director of Economic Affairs of the Interfarma, the Brazilian association of the Pharma Industry; and Luis Cassapula and Amèrico Souza, Serialization Project Manager and IT Lead respectively at Brazilian Aché. After the user group event, there will be an open houses and product demonstrations for selected customers and sales channel representatives.

Family, members of the public and contemporary art

On Saturday 24 October, the company will open its doors to employee families and will feature product demonstrations as well as building tours and refreshments. On Sunday, the public will have the opportunity to become acquainted with pharmaceutical inspection and tracking and tracing systems. The public will also have the opportunity of seeing for the first time a collection of contemporary works by noted Italian artist Davide Mancini Zanchi. The contemporary pieces, which will be on permanent display, are based on actual pharmaceutical plant images taken with Antares Vision machine vision systems. Zanchi’s interpretations of these images are digitally printed on metal photo panels.

Technology leaders at pharmaceutical cmpanies large and small should visit to learn more about the company’s extensive line of products and systems and its passion to help customers succeed in serialization and track and trace. A complete list of the company’s international offices, including sales partners, is available on the website.